Global Pharmaceutical Analytical Testing Outsourcing Market Is Set For Moderate Growth, To Reach Around USD 17.27 Billion By 2032

Zion Market Research has published a new report titled “Pharmaceutical Analytical Testing Outsourcing Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024-2032”. According to the report, global demand for the pharmaceutical analytical testing outsourcing market was valued at approximately USD 8.32 billion in 2023 and is expected to generate revenue of around USD 17.27 billion by the end of 2032, growing at a CAGR of around 8.57% between 2024 and 2032.

Browse the full “Pharmaceutical Analytical Testing Outsourcing Market By Product (Raw Materials, Active Pharmaceutical Ingredients And Finished Products), By Services (Method Development & Validation, Stability Testing, Bioanalytical Testing And Others), and By Region: Global Industry Perspective, Comprehensive Analysis And Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/pharmaceutical-analytical-testing-outsourcing-market

Analytical testing is a crucial step in the pharmaceutical and biopharmaceutical quality management system. Analytical testing is an important process and an integral part of the drug manufacturing process. Identification, purification of impurities and compounds, active pharmaceutical ingredients characterization, analytical method development and validation, stability testing, etc. are some of the major analytical tests used during drug manufacturing. Analytical testing outsourcing of biopharmaceutical and pharmaceutical products is widely preferred across the industry owing to various factors such as the growing need to speed up the overall product development and commercialization process along with the increasing number of pipeline products, the need to reduce overall cost and faster regulatory approvals.

The pharmaceutical analytical testing outsourcing market is majorly driven by increasing focus on biopharmaceutical and biosimilar testing, growth in new biopharmaceutical development, and increasing adoption of outsourcing activities. Other factors such as increasing investments, growing demand for biosimilar and other new pharmaceutical therapeutics, increasing registrations for clinical trials, and entry of new contract organizations have widely influenced the growth of the pharmaceutical analytical testing outsourcing market. However, regulatory audits and quality approvals may hamper the growth of this market.

The study provides a crucial view on pharmaceutical analytical testing outsourcing by segmenting the market based on product type, solution type, end user, and region. Based on product market is segmented into raw materials, active pharmaceutical ingredients and finished products. The active pharmaceutical ingredient product segment is expected to grow at the highest CAGR over the forecast period. This growth is attributed to increasing demand for biosimilars, monoclonal antibodies, generic drugs, etc. for treating various chronic disorders.

Based on services, the global pharmaceutical analytical testing outsourcing market is bifurcated into method development & validation, bioanalytical testing, stability testing and others. bioanalytical testing segment is further sub-categorized into nonclinical and clinical. The stability testing segment is further split into stability indicating method validation, drug substance, photostability testing, accelerated stability testing and others. The method development & validation segment is further split into impurity method, technical consulting, extractable & leachable and others. The bioanalytical testing segment accounted for the largest market share in 2023 and the clinical bioanalytical testing segment is expected to grow at the highest CAGR over the forecast period. The stability testing segment is projected to witness the highest growth rate over the forecast period.

At the regional level, North America held the largest revenue share in 2023 for the global pharmaceutical analytical testing outsourcing market. Increasing investments in biosimilars, new chemical entities (NCEs), monoclonal antibodies, and therapeutic peptides research and development, strong presence of major biopharmaceutical manufacturers, and favorable government support attribute to the leading market share in North America. Europe was the second leading regional market in 2023 due to growing investments by major players, the availability of ample funds for R&D, the presence of developed infrastructure for R&D, etc. The fastest growth is projected in the Asia Pacific region over the forecast period. This fast growth is attributed to the developed pharmaceutical generics market in China and India and the presence of major contract research organizations. Latin America and Middle East and Africa regions will register noticeable growth over the forecast period. 

Major players included in the report are SGS SA, Intertek Group PLC, Exova Group PLC, Toxikon, Inc., Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc., Eurofins Scientific, West Pharmaceutical Services, Inc., Pace Analytical Services, LLC, and Boston Analytical, Inc.

The report segments of the global pharmaceutical analytical testing outsourcing market as follows:

Global Pharmaceutical Analytical Testing Outsourcing Market: By Product Type

• Raw Materials
• Active Pharmaceutical Ingredients
• Finished Products

Global Pharmaceutical Analytical Testing Outsourcing Market: By Services

• Bioanalytical Testing
  • Clinical
  • Non Clinical
• Method Development & Validation
  • Extractable & Leachable
  • Impurity Method
  • Technical Consulting
  • Others
• Stability Testing
  • Drug Substance
  • Stability Indicating Method Validation
  • Accelerated Stability Testing
  • Photostability Testing
  • Others
• Others

Global Pharmaceutical Analytical Testing Outsourcing Market: By Region

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com